Alba Grifoni
La Jolla Institute for Immunology(US)La Jolla Alcohol Research(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, Immunotherapy and Immune Responses, Mosquito-borne diseases and control
Most-Cited Works
- → Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals(2020)4,008 cited
- → Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection(2021)2,976 cited
- → Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity(2020)1,957 cited
- → Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans(2020)1,275 cited
- → A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2(2020)1,079 cited
- → Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome(2020)992 cited
- → mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern(2021)916 cited
- → SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron(2022)907 cited
- → Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals(2021)669 cited
- → T cell responses to SARS-CoV-2 spike cross-recognize Omicron(2022)615 cited